08372.HK
Grand Brilliance Group Holdings Limited
HKSE · Healthcare · Medical - Distribution · HK
HKD 0.16
+10.34%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 124.8M | 100.7M | 94.4M | 81.9M | 76.7M |
| Cost of Revenue | 67.3M | 56.9M | 48.7M | 40.0M | 37.2M |
| Gross Profit | 57.5M | 43.8M | 45.7M | 41.9M | 39.5M |
| Operating Expenses | |||||
| R&D Expense | 6.0M | 4.6M | 3.9M | 4.1M | 2.5M |
| SG&A Expense | 39.6M | 36.8M | 35.5M | 36.7M | 31.7M |
| General & Admin Expense | 37.9M | 35.3M | 34.1M | 35.4M | 30.5M |
| Selling & Marketing Expense | 1.5M | 1.5M | 1.4M | 1.3M | 1.2M |
| Other Expenses | 6.5M | (4.3M) | (2.0M) | 18.0K | (79.0K) |
| Total Operating Expenses | 52.1M | 37.0M | 37.4M | 40.8M | 34.1M |
| Cost and Expenses | 119.4M | 94.0M | 86.2M | 76.4M | 69.1M |
| Operating Income (EBIT) | 3.5M | 6.8M | 8.3M | 5.5M | 7.6M |
| Non-Operating | |||||
| Interest Income | 940.0K | 940.0K | 1.6M | 1.7M | 438.0K |
| Interest Expense | 214.0K | 214.0K | 208.0K | 106.0K | 152.0K |
| Net Interest Income | 1.1M | 726.0K | 1.4M | 1.6M | 286.0K |
| Other Non-Op Income/Expense | 2.3M | 2.3M | 1.8M | 2.7M | 1.7M |
| Non-Operating Income (excl Interest) | (4.6M) | — | (2.0M) | (3.1M) | (2.1M) |
| EBT (Pre-Tax Income) | 9.0M | 9.0M | 10.1M | 8.2M | 9.4M |
| Income Tax Expense | 1.0M | 937.0K | 917.0K | 420.0K | 1.8M |
| Bottom Line | |||||
| Net Income | 10.6M | 8.4M | 9.5M | 7.9M | 7.6M |
| Earnings from Cont. Ops | 8.1M | 8.1M | 9.2M | 7.8M | 7.6M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 10.6M | 8.4M | 9.5M | 7.9M | 7.6M |
| Per Share | |||||
| Basic EPS | HK$0.01 | HK$0.01 | HK$0.01 | HK$0.01 | HK$0.01 |
| Diluted EPS | HK$0.01 | HK$0.01 | HK$0.01 | HK$0.01 | HK$0.01 |
| Revenue Per Share | HK$0.16 | HK$0.13 | HK$0.12 | HK$0.10 | HK$0.10 |
| Shares | |||||
| Basic Shares Outstanding | 794.2M | 800.0M | 800.0M | 800.0M | 800.0M |
| Diluted Shares Outstanding | 794.2M | 800.0M | 800.0M | 800.0M | 800.0M |
| Profitability Metrics | |||||
| EBITDA | 9.3M | 9.3M | 14.0M | 13.2M | 14.1M |
| D&A | 2.6M | 2.6M | 3.6M | 4.6M | 4.4M |
| EBIT | 6.8M | 6.8M | 10.3M | 8.6M | 9.7M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026